New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines to send his nomination to the full chamber.
No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...
Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...
Henceforth, you need to master these skills to thrive in the corporate workspace. Read the blog to get the formal letter format, samples, and tips that will help you create a professional letter. It ...
Even if you’re conservative in your choice of bed sheets — crisp, white percale sheets, for example — a duvet cover gives you a chance to experiment with color, texture, pattern, and ...
In this article, we will explore the key components of an authorization letter, provide samples for various scenarios, and offer valuable writing tips to ensure your letters are clear, concise, and ...
Instead, pharmacy benefit managers — which determine what drugs insurers cover under what terms — wouldn’t put the unbranded drug into their formularies. Insurers wouldn’t cover or would ...
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.
All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. Receive The Pharma ...
Outgoing presidents traditionally leave a letter for the incoming president. Former President Joe Biden wished President Donald Trump "all the best for the next four years" in the letter he left ...
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...